Strategies for iron supplementation: Oral versus intravenous

Slides:



Advertisements
Similar presentations
Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup
Advertisements

Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Steven Fishbane, Jeffrey S. Berns, M.D.  Kidney International 
Volume 69, Issue 5, Pages (March 2006)
Volume 88, Issue 5, Pages (November 2015)
Iron indices: What do they really mean?
A. Besarab  Kidney International  Volume 69, Pages S13-S18 (May 2006)
New options for the anemia of chronic kidney disease
Volume 70, Issue 8, Pages (October 2006)
Iron status and iron supplementation in peritoneal dialysis patients
Anemia management in chronic kidney disease
American Journal of Kidney Diseases 
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Volume 64, Pages S72-S77 (November 2003)
ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target  Szu-Chun Hung, Der-Cherng Tarng  Kidney International 
Progression of renal failure and hypertensive nephrosclerosis
Francesco Paolo Schena  Kidney International 
Volume 62, Issue 2, Pages (August 2002)
Chapter 2: Use of iron to treat anemia in CKD
Volume 70, Pages S21-S25 (December 2006)
Volume 77, Issue 1, Pages 5-6 (January 2010)
D. Batlle, P. Ramadugu, M.J. Soler  Kidney International 
A new era in phosphate binder therapy: What are the options?
Darbepoetin alfa: A new therapeutic agent for renal anemia
Volume 70, Issue 11, Pages (December 2006)
Joseph W. Eschbach, John W. Adamson  Kidney International 
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
The epidemiology of chronic kidney disease
Volume 73, Pages S5-S17 (April 2008)
Volume 60, Issue 6, Pages (December 2001)
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Kenar D. Jhaveri, Steven Fishbane  Kidney International 
Blood pressure targets in hemodialysis patients
Volume 67, Issue 1, Pages (January 2005)
Volume 78, Issue 2, Pages (July 2010)
Recent experience with high-dose intravenous iron administration
Disaster nephrology: crush injury and beyond
A physician's perseverance uncovers problems in a key nephrology study
Günter Weiss, Florian Kronenberg  Kidney International 
Francesco Locatelli, Lucia Del Vecchio  Kidney International 
Volume 64, Pages S72-S77 (November 2003)
Clifford J. Holmes, Dirk Faict  Kidney International 
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
The value of ferric citrate, an iron-containing phosphate binder, might be different between Japan and the United States  Keitaro Yokoyama, Yukio Maruyama,
Simvastatin in nephrotic syndrome
Profiling of peritoneal ultrafiltration
Erythropoietin and iron
Volume 56, Pages S213-S215 (July 1999)
Cardiovascular risk assessment in kidney transplantation
Volume 55, Issue 5, Pages (May 1999)
Hemoglobin variability in epoetin-treated hemodialysis patients
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Current status of maintenance hemodialysis in Beijing, China
Phosphate binders on iron basis: A new perspective?
Organ transplantation goes to the movies
Volume 55, Pages S3-S16 (June 1999)
The Danish Renal Biopsy Register
Volume 63, Issue 3, Pages (March 2003)
Cellular iron metabolism
Charles A. Herzog  Kidney International 
(A) Mean (SD) serum continuous erythropoietin receptor activator (C. E
Review of clinical trial experience with icodextrin
Volume 70, Issue 5, Pages (September 2006)
The International Pediatric Peritonitis Registry: Starting to walk
Attitudes and predictive factors for live kidney donation: A comparison of live kidney donors versus nondonors  Lynn Stothers, William A. Gourlay, Li.
Ronen Levi, Justin Silver  Kidney International 
Presentation transcript:

Strategies for iron supplementation: Oral versus intravenous Iain C. Macdougall  Kidney International  Volume 55, Pages S61-S66 (March 1999) DOI: 10.1046/j.1523-1755.1999.055Suppl.69061.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Hemoglobin response (mean ±SD) in three groups of erythropoietin-treated patients with different regimens of iron supplementation. Symbols are: (•) i.v. iron; (○) oral iron; (▪) no iron; *P < 0.05; **P < 0.005 vs. i.v. iron-treated group. Taken from Macdougall et al22; used with permission. Kidney International 1999 55, S61-S66DOI: (10.1046/j.1523-1755.1999.055Suppl.69061.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 Mean hematocrit in two groups of patients receiving erythropoietin. Squares indicate the intravenous iron group; diamonds indicate the oral iron group. *P < 0.05. Taken from Fishbane et al20; used with permission. Kidney International 1999 55, S61-S66DOI: (10.1046/j.1523-1755.1999.055Suppl.69061.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Kidney International 1999 55, S61-S66DOI: (10. 1046/j. 1523-1755. 1999 Kidney International 1999 55, S61-S66DOI: (10.1046/j.1523-1755.1999.055Suppl.69061.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Kidney International 1999 55, S61-S66DOI: (10. 1046/j. 1523-1755. 1999 Kidney International 1999 55, S61-S66DOI: (10.1046/j.1523-1755.1999.055Suppl.69061.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Kidney International 1999 55, S61-S66DOI: (10. 1046/j. 1523-1755. 1999 Kidney International 1999 55, S61-S66DOI: (10.1046/j.1523-1755.1999.055Suppl.69061.x) Copyright © 1999 International Society of Nephrology Terms and Conditions